Finance

Lists
GYRE:NASDAQ
Gyre Therapeutics Inc
7,04 $
-0,56%
(-0,040) 1D
7,04 $
0,00% (0,00)
After hours
Closed: 7 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GYRE...
Open
7,03 $
High
7,14 $
Low
6,99 $
Mkt. cap
746,48 մլն
Avg. vol.
160,94 հզր
Volume
0,00
52-wk high
9,42 $
52-wk low
5,44 $
EPS
-0,20 $
Beta
2,18
Shares outstanding
106,03 մլն
No. of employees
625
Open
7,03 $
High
7,14 $
Low
6,99 $
Mkt. cap
746,48 մլն
Avg. vol.
160,94 հզր
Volume
0,00
52-wk high
9,42 $
52-wk low
5,44 $
EPS
-0,20 $
Beta
2,18
Shares outstanding
106,03 մլն
No. of employees
625
News stories
From web sources and news partners
About Gyre Therapeutics Inc
CEO-
Employees625
Founded1997
HeadquartersՈւնիստոն-Սեյլեմ, Հյուսիսային Կարոլինա, Միացյալ Նահանգներ
Sector-
Websitegyretx.com
Analyst ratings
Based on 2 analysts giving stock ratings to GYRE in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for GYRE in the last 3 months.
Highest
Current 7,04 $
20,00 $ (+184,09%)
Average
19,00 $ (+169,89%)
Lowest
18,00 $ (+155,68%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Keller
H.C. Wainwright
Buy
Reiterated
18,00 $
+155,7%
10/05/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
20,00 $
+184,1%
08/10/2026
Roger Song
Jefferies
Buy
Initiated
16,00 $
+127,3%
10/10/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
30,56 մլն
37,20 մլն
24,43 մլն
29,10 մլն
Cost of goods sold
1,63 մլն
1,74 մլն
1,23 մլն
2,21 մլն
Cost of revenue
1,63 մլն
1,74 մլն
1,23 մլն
2,21 մլն
Research and development expenses
2,36 մլն
4,82 մլն
11,48 մլն
19,14 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,65 մլն
30,52 մլն
24,31 մլն
21,62 մլն
Operating expense
22,01 մլն
35,33 մլն
35,79 մլն
40,76 մլն
Total operating expenses
23,64 մլն
37,08 մլն
37,02 մլն
42,97 մլն
Operating income
6,93 մլն
120,00 հզր
-12,59 մլն
-13,86 մլն
Other non operating income
604,00 հզր
-2,31 մլն
244,00 հզր
-811,00 հզր
EBT including unusual items
7,63 մլն
-66,00 հզր
-18,03 մլն
-14,43 մլն
EBT excluding unusual items
7,63 մլն
-864,00 հզր
-11,65 մլն
-13,93 մլն
Income tax expense
1,69 մլն
1,30 մլն
549,00 հզր
-164,00 հզր
Effective tax rate
22,19%
-1 969,70%
-3,04%
1,14%
Other operating expenses
-
-
-
-
Net income
3,61 մլն
-1,72 մլն
-10,30 մլն
-10,60 մլն
Net profit margin
11,81%
-4,63%
-42,16%
-36,44%
Earnings per share
0,03
0,05
-
-
Interest and investment income
100,00 հզր
1,35 մլն
743,00 հզր
740,00 հզր
Interest expense
-
-
-
-
Net interest expenses
100,00 հզր
1,35 մլն
743,00 հզր
740,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
7,58 մլն
815,00 հզր
-11,92 մլն
-12,38 մլն
Gain or loss from assets sale
1,00 հզր
2,00 հզր
16,00 հզր
2,00 հզր
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps